ARCHIVES

Gleevec Better Than Interferon For Newly Diagnosed CML

This article is from The Cancer Letter archive.

Vol. 25 No. 5 | May 31, 2002

Download PDF Visit The Full Archive

Related Articles

In Congress: Senate Committee Provides Increase To DOD Program

August 1, 1997

Abstracts Of ‘Most Newsworthy’ Papers

June 10, 1977

In Brief: What’s In A Name? DRCCA Doesn’t Do It; O’Conor Says ICRDB Program Should Consider New Challenges

October 3, 1980

New Regimens May Benefit Multiple Myeloma Patients

January 28, 2005

Senate Emphasizes Balance In NCI’s Research Programs

September 24, 1993

DCE Board Approves New Study to Seek Causes Of Rising Breast Cancer Incidence In Young Women

May 27, 1988